Single dose Peramivir for the Treatment of Acute Seasonal Influenza: Integrated Analysis of Efficacy and Safety from Two Placebo-Controlled Trials
Antiviral Therapy2014Vol. 20(7), pp. 709–719
Citations Over TimeTop 15% of 2014 papers
Richard J. Whitley, Alan Laughlin, Simon Carson, Essack Mitha, Guy Tellier, Mark Stich, Jenna Elder, W James Alexander, Sylvia Dobo, Phil Collis, William Sheridan
Abstract
The results of these studies are consistent with previous reports of peramivir administered by intravenous infusion, and demonstrate a positive risk-benefit profile for peramivir in patients with acute uncomplicated influenza.
Related Papers
- → In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705(2002)500 cited
- → In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication(2002)101 cited
- → Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors(2017)16 cited
- → Effect of Influenza Anti-Neuraminidase Antibody on Virus Neutralization(1973)10 cited
- Determination of anti-influenza virus neuraminidase activity of L20051117 and AMMS607(2009)